Jpmorgan Chase & CO Conmed Corp Transaction History
Jpmorgan Chase & CO
- $1.14 Trillion
- Q2 2024
A detailed history of Jpmorgan Chase & CO transactions in Conmed Corp stock. As of the latest transaction made, Jpmorgan Chase & CO holds 313,795 shares of CNMD stock, worth $22.1 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
313,795
Previous 449,453
30.18%
Holding current value
$22.1 Million
Previous $36 Million
39.56%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding CNMD
# of Institutions
312Shares Held
35.6MCall Options Held
122KPut Options Held
29.9K-
Black Rock Inc. New York, NY4.99MShares$352 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.49MShares$246 Million0.0% of portfolio
-
Earnest Partners LLC Atlanta, GA2.82MShares$199 Million0.95% of portfolio
-
Capital Research Global Investors Los Angeles, CA1.71MShares$120 Million0.03% of portfolio
-
Bank Of America Corp Charlotte, NC1.32MShares$93.3 Million0.01% of portfolio
About CONMED Corp
- Ticker CNMD
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 30,482,400
- Market Cap $2.15B
- Description
- CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for surgical procedures worldwide. It offers orthopedic surgery products, including TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and PopLok Knotless Suture Anchors, which provide uni...